Author:
Stalinska J.,Zimolag E.,Pianovich NA.,Zapata A.,Lassak A.,Rak M.,Dean M.,Ucar-Bilyeu D.,Wyczechowska D.,Culicchia F.,Marrero L.,Del Valle L.,Sarkaria J.,Peruzzi F.,Jursic BS,Reiss K.
Funder
LSUHSC, Dean of School of Medicine
LSUHSC, Dean of School of Medicine matching funds
Louisiana Clinical and Translational Science Center
Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian Universit
Reference54 articles.
1. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer;Drukala,2010
2. Inhibition of melanoma metastases by fenofibrate;Grabacka;Arch Dermatol Res,2004
3. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt;Grabacka;Clin Cancer Res,2006
4. Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier;Grabacka;J Physiol Pharmacol,2015
5. Fenofibrate induces ketone body production in melanoma and glioblastoma cells;Grabacka;Front Endocrinol,2016
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献